Skip to main content
Premium Trial:

Request an Annual Quote

Tuschl Wins Max Delbrueck Medal; Adam Joins Applera's Board; Ludesi Adds Proteomics Expertise; and Others

NEW YORK (GenomeWeb News) - Rockefeller University professor Thomas Tuschl was awarded the Max Delbrück Medal by the Max Delbrück Center for Molecular Medicine in Berlin for his pioneering work in RNAi.
 
Among Tuschl’s discoveries was that RNAi existed in mammalian cells and could be triggered using short dsRNA.
 

 
Applera has named George Adam to its board of directors. The firm said the board now has 11 members, and that it expects several to retire over the next few years. The company said it also may need extra directors in the event that it decides to separate its Applied Biosystems and Celera businesses into two distinct groups, an option it has been considering since August.
 

 
Ludesi has hired Krisztina Halasz, Anna Kapferer, and Helena Lexander as application specialists.
Halasz formerly was account manager and product specialist at Bio-Rad Laboratories, Kapferer was an engineer at Nonlinear Dynamics, and Lexander was involved in proteomics at GE Healthcare and at Oxford Genome Sciences.

 
Samir Brahmachari, who is director of the Institute of Genomics and Integrative Biology in Delhi, India, has been named chief of the Council of Scientific and Industrial Research and secretary of the Department of Scientific and Industrial Research. Brahmachari formerly was involved in functional genomics and led the Indian Genome Variation Consortium.
 

 
Lucy Greene has been named associate director for management at the National Institute of Diabetes and Digestive and Kidney Diseases. Greene will serve as the executive officer and will advise the director and other officials on administrative management.
 

 
Pacific Biometrics has appointed Edwin Merrifield to the post of director of biomarker and technical operations. In that role, Merrifield will direct the company’s new clinical biomarker services business.
 

 
David Voris has moved into the office of VP of finance and administration and CFO at Cyntellect. He formerly was CFO at SynergEyes and was involved in finance and operations at Alaris Medical Systems and at Metracor Technologies.
 

 
Gene Express has named Larissa Karnaoukhova director of strategic partnerships, a role in which she will oversee business development on the US west coast. Karnaoukhova formerly was a sales manager at VWR International and was a scientist at Invitrogen.
 

 
Alnylam has appointed Stuart Pollard to be VP of scientific and business strategy and Donna Ward to the post of VP of intellectual property.
 
Pollard formerly was in business development at Maxygen and was at Biogen for ten years. Ward was a patent attorney with Elmore Patent Law Group and she managed chemistry and biology portfolios at Isis Pharmaceuticals.
 

 
Ileana Collado Herrell has been named director of the division of scientific strategic planning and policy analysis at the National Center on Minority Health and Health Disparities.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.
 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.